 |
124 Diseases |  |
24 Trials |
|
24 Trials |  |
2082 News |  |
| «12...14151617181920212223242526 |
- Rybelsus (semaglutide oral) / Novo Nordisk
New P1 trial: A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects (clinicaltrials.gov) - Feb 23, 2014
P1, N=52, Recruiting, Sponsor: Novo Nordisk A/S
- Trial completion: COACH: Reducing Total Cardiovascular Risk in an Urban Community (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=525, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed
- | lisinopril / Generic mfg.
Trial completion: Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=60, Completed, Sponsor: Steno Diabetes Center
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| carvedilol / Generic mfg., atenolol / Generic mfg., lisinopril / Generic mfg.
Trial completion, Combination therapy: The CLEVER Study - Coreg And Left Ventricular Mass Regression (clinicaltrials.gov) - Feb 22, 2014
P3, N=287, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Active, not recruiting --> Completed
- atorvastatin / Generic mfg., lisinopril / Generic mfg.
Trial initiation date, Surgery: OPTMIZE-OS: Risk Factor Control Before Orthopedic Surgery (clinicaltrials.gov) - Feb 12, 2014
P4, N=550, Recruiting, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Initiation date: Apr 2013 --> Feb 2014
- atorvastatin / Generic mfg., lisinopril / Generic mfg.
Enrollment open, Surgery: OPTMIZE-OS: Risk Factor Control Before Orthopedic Surgery (clinicaltrials.gov) - Feb 12, 2014
P4, N=550, Recruiting, Sponsor: New York University School of Medicine
Initiation date: Apr 2013 --> Feb 2014 Not yet recruiting --> Recruiting
- | Trial completion: Action to Control Cardiovascular Risk in Diabetes (ACCORD) (clinicaltrials.gov) - Feb 6, 2014
P3, N=10251, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial termination: Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors (clinicaltrials.gov) - Jan 13, 2014
P2, N=6, Terminated, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed Recruiting --> Terminated; slow accrual
- lisinopril / Generic mfg.
Trial completion: PTN_LISINO: Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant (clinicaltrials.gov) - Dec 17, 2013
P1, N=26, Completed, Sponsor: Uptal Patel
Recruiting --> Terminated; slow accrual Recruiting --> Completed
- || candesartan cilexetil / Generic mfg., lisinopril / Generic mfg.
New P3 trial: CALIBREX: CAndesartan vs LIsinopril Effects on the BRain (clinicaltrials.gov) - Nov 12, 2013
P3, N=140, Not yet recruiting, Sponsor: Ihab Hajjar
- simvastatin / Generic mfg., hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
Trial completion: The Evening Versus Morning Polypill Utilization Study (clinicaltrials.gov) - Aug 11, 2013
P=N/A, N=78, Completed, Sponsor: UMC Utrecht
Recruiting --> Completed Recruiting --> Completed
- lisinopril / Generic mfg.
Enrollment change: The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study (clinicaltrials.gov) - Jul 28, 2013
P=N/A, N=30, Recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed N=45 --> 30
- | lisinopril / Generic mfg.
New P2 trial: ACSRD: Renal Denervation in Patients After Acute Coronary Syndrome (clinicaltrials.gov) - Jul 15, 2013
P2, N=80, Recruiting, Sponsor: Meshalkin Research Institute of Pathology of Circulation
- | Enrollment change: HALT Progression of Polycystic Kidney Disease Study A (clinicaltrials.gov) - Jun 26, 2013
P3, N=548, Active, not recruiting, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
N=45 --> 30 N=1018 --> 548
- || New P3 trial: HALT Progression of Polycystic Kidney Disease Study B (clinicaltrials.gov) - Jun 23, 2013
P3, N=486, Active, not recruiting, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- | Enrollment closed: HALT Progression of Polycystic Kidney Disease Study B (clinicaltrials.gov) - Jun 19, 2013
P3, N=486, Active, not recruiting, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
N=1018 --> 548 Not yet recruiting --> Active, not recruiting
- lisinopril / Generic mfg.
Clinical: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer (clinicaltrials.gov) - Jun 17, 2013
P=N/A, N=50, Recruiting, Sponsor: Mayo Clinic
- | atenolol / Generic mfg., lisinopril / Generic mfg.
Enrollment closed: Hypertension in Hemodialysis Patients (Aim 3) (clinicaltrials.gov) - May 21, 2013
P3, N=200, Active, not recruiting, Sponsor: Indiana University
Not yet recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | atorvastatin / Generic mfg., lisinopril / Generic mfg.
New P4 trial, Surgery: OPTMIZE-OS: Risk Factor Control Before Orthopedic Surgery (clinicaltrials.gov) - Apr 18, 2013
P4, N=550, Recruiting, Sponsor: New York University School of Medicine
- | hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
New P1 trial: Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions (clinicaltrials.gov) - Apr 11, 2013
P1, N=48, Completed, Sponsor: IPCA Laboratories Ltd.
- | hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
New P1 trial: Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions (clinicaltrials.gov) - Apr 8, 2013
P1, N=48, Completed, Sponsor: IPCA Laboratories Ltd.
- Enrollment change: AVEC: The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (clinicaltrials.gov) - Jan 13, 2013
P2, N=53, Completed, Sponsor: University of Southern California
Recruiting --> Active, not recruiting N=100 --> 53
- ||| aleglitazar (R1439) / Roche
Trial completion: A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril (clinicaltrials.gov) - Jan 13, 2013
P1, N=55, Completed, Sponsor: Hoffmann-La Roche
N=100 --> 53 Active, not recruiting --> Completed
- Trial completion: AVEC: The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (clinicaltrials.gov) - Jan 13, 2013
P2, N=53, Completed, Sponsor: University of Southern California
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| carvedilol controlled-release / Generic mfg.
Enrollment closed: Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI. (clinicaltrials.gov) - Dec 16, 2012
P4, N=60, Active, not recruiting, Sponsor: Kaleida Health
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- lisinopril / Generic mfg.
Enrollment open: The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study (clinicaltrials.gov) - Nov 29, 2012
P=N/A, N=30, Recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | lisinopril / Generic mfg.
New P1 trial: Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition (clinicaltrials.gov) - Nov 26, 2012
P1, N=40, Completed, Sponsor: IPCA Laboratories Ltd.
- | lisinopril / Generic mfg.
New P1 trial: Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition (clinicaltrials.gov) - Nov 26, 2012
P1, N=40, Completed, Sponsor: IPCA Laboratories Ltd.
- Enrollment change: Black Education and Treatment of Hypertension (BEAT HTN) (clinicaltrials.gov) - Nov 5, 2012
P4, N=99, Completed, Sponsor: Creighton University
Not yet recruiting --> Recruiting N=160 --> 99
- | losartan / Generic mfg., lisinopril / Generic mfg.
Enrollment closed: VA NEPHRON-D: Diabetes iN Nephropathy Study (clinicaltrials.gov) - Oct 3, 2012
P3, N=1448, Active, not recruiting, Sponsor: Department of Veterans Affairs
N=160 --> 99 Recruiting --> Active, not recruiting
- lisinopril / Generic mfg.
Enrollment open: The VALIDATE-D Study (clinicaltrials.gov) - Sep 18, 2012
P=N/A, N=40, Recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | New P4 trial, Surgery: Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery (clinicaltrials.gov) - Aug 19, 2012
P4, N=300, Not yet recruiting, Sponsor: University of Nebraska
- simvastatin / Generic mfg., hydrochlorothiazide / Generic mfg., lisinopril / Generic mfg.
Trial initiation date: The Evening Versus Morning Polypill Utilization Study (clinicaltrials.gov) - Aug 12, 2012
P=N/A, N=78, Completed, Sponsor: UMC Utrecht
Not yet recruiting --> Recruiting Initiation date: Jan 2012 --> Jul 2012
- atenolol / Generic mfg., lisinopril / Generic mfg.
Enrollment change: Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study (clinicaltrials.gov) - Jun 17, 2012
P=N/A, N=100, Recruiting, Sponsor: Brigham and Women's Hospital
Initiation date: Jan 2012 --> Jul 2012 N=200 --> 100
- Trial completion, Metastases: Curing Atrial Fibrillation in Heart Failure (clinicaltrials.gov) - May 28, 2012
P=N/A, N=41, Completed, Sponsor: NHS Greater Glasgow and Clyde
N=200 --> 100 Recruiting --> Completed
- Avastin (bevacizumab) / Roche, Bystolic (nebivolol) / Menarini, AbbVie
Trial withdrawal: Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab (clinicaltrials.gov) - Apr 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Mississippi Medical Center
Recruiting --> Completed Recruiting --> Withdrawn
- Avastin (bevacizumab) / Roche, Bystolic (nebivolol) / Menarini, AbbVie
Enrollment change: Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab (clinicaltrials.gov) - Apr 4, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Mississippi Medical Center
Recruiting --> Withdrawn N=20 --> 0
- perindopril arginine / Generic mfg., lisinopril / Generic mfg.
New P4 trial: Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients (clinicaltrials.gov) - Apr 3, 2012
P4, N=43, Completed, Sponsor: Turkish Nephrology Association
- | simvastatin / Generic mfg., atenolol / Generic mfg., lisinopril / Generic mfg.
Trial initiation date: Single Pill to Avert Cardiovascular Events (clinicaltrials.gov) - Mar 14, 2012
P3, N=2000, Not yet recruiting, Sponsor: Hospital do Coracao
N=20 --> 0 Initiation date: Aug 2011 --> Oct 2012
- lisinopril / Generic mfg.
New P4 trial: ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study (clinicaltrials.gov) - Feb 15, 2012
P4, N=30, Recruiting, Sponsor: University of California, San Francisco
- | sildenafil / Generic mfg., lisinopril / Generic mfg.
Trial completion: Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) (clinicaltrials.gov) - Feb 2, 2012
P=N/A, N=24, Completed, Sponsor: Mayo Clinic
Initiation date: Aug 2011 --> Oct 2012 Recruiting --> Completed
- |||| lisinopril / Generic mfg.
Trial completion: Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease (clinicaltrials.gov) - Feb 2, 2012
P1/2, N=100, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Victoza (liraglutide) / Novo Nordisk
New P1 trial: Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH (clinicaltrials.gov) - Jan 16, 2012
P1, N=70, Completed, Sponsor: Novo Nordisk
- lisinopril / Generic mfg.
New P1 trial: PTN_LISINO: Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant (clinicaltrials.gov) - Dec 12, 2011
P1, N=26, Completed, Sponsor: Uptal Patel
- valsartan / Generic mfg., lisinopril / Generic mfg.
Enrollment change: Antialbuminuric Effects of Valsartan and Lisinopril (clinicaltrials.gov) - Nov 6, 2011
P4, N=54, Terminated, Sponsor: Novartis
Active, not recruiting --> Completed N=201 --> 54
- || New P3 trial: Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients? (clinicaltrials.gov) - Aug 30, 2011
P3, N=80, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- ||| Trulicity (dulaglutide) / Eli Lilly
Trial completion: A Study of the Effect of LY2189265 on Two Blood Pressure Drugs (clinicaltrials.gov) - Aug 15, 2011
P1, N=56, Completed, Sponsor: Eli Lilly and Company
N=201 --> 54 Active, not recruiting --> Completed